首页> 外文OA文献 >A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

【2h】

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

机译：一项II期临床试验，以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tsuburaya, Akira Tsuburaya; Morita, Satoshi; Kodera, Yasuhiro; Kobayashi, Michiya; Shitara, Kohei; Yamaguchi, Kensei; Yoshikawa, Takaki; Yoshida, Kazuhiro; Yoshino, Shigefumi; Sakamoto, Jun-ichi;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 食管癌患者同期放化疗顺铂加氟尿嘧啶方案Ⅱ期临床试验 [J] . 蔺强, 高献书, 乔学英, 癌症（英文版） . 2008,第010期
2. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) [J] . Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, BMC Cancer . 2012,第1期

机译：一项II期临床试验，以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）
3. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) [J] . Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, BMC Cancer . 2012,第1期

机译：一项II期随机试验，以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）
4. A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II) [J] . Nishikawa Kazuhiro, Tsuburaya Akira, Yoshikawa Takaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：Capecitabine Plus顺铂的随机期II试验与S-1加顺铂作为晚期胃癌的一线治疗：Capecitabine Plus顺铂确定与S-1加上顺铂随机化PII试验（XParts II）
5. Clinical studies of SP1049C, a polymer based anthracycline effective against drug resistant tumors. Results of phase II trial and pivotal phase Ⅲ program in upper gastrointestinal cancer indications [C] . Valery Alakhov Controlled Release Society Annual Meeting and Exposition . 2007

机译：SP1049C的临床研究，一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
6. Phase II double-blinded randomized controlled clinical trial of chondroitinase ABC by intraspinal injection for treatment of severe chronic spinal cord injury in 60 pet dogs. [D] . Hu, Hilary. 2016

机译：脊髓内注射软骨素酶ABC的II期双盲随机对照临床试验，用于治疗60只宠物狗的严重慢性脊髓损伤。
7. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) [O] . Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, 2012

机译：一项II期临床试验以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）
8. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) [O] . 2012

机译：一项II期临床试验，以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

著录项

相似文献

相关主题

期刊订阅